Soricimed in-licenses peptide from UHN

Closely held Soricimed Biopharma has in-licensed a proprietary peptide from the University Health Network, which was developed by Dr. Mansoor Husain at his lab at the University of Toronto. “Dr. Husain looked at a series of cell lines and showed that the peptide was able to stop growth in cervical, bone and lung cancer cells,” [...]

Shrew saliva may detect and treat cancer

Paralytic venom in the saliva of the tiny North American short-tailed shrew, which hunts its prey on the forest floor, may hold the key to a diagnostic and therapeutic treatment for ovarian, breast and prostate cancers. “We found out that the paralytic agent in the venom was a peptide material that we eventually named soricidin,” [...]